{"package_id":"USCOURTS-cofc-1_07-vv-00448","decision_granule_id":"USCOURTS-cofc-1_07-vv-00448-cl6661919","petitioner_identifier":"John Doe 93","is_minor":0,"age_at_vaccination":61.0,"age_unit_raw":"years","vaccine_type":"influenza","vaccination_date":"2004-10-08","condition_raw":"transverse myelitis","condition_category":"transverse_myelitis","autism_spectrum_adjacent":0,"outcome":"unclear","award_amount_usd":null,"decision_date":"2011-04-29","extraction_version":"gemini-v2","extracted_at":"2026-04-30T14:30:56.780046+00:00","number_of_concurrent_vaccines":1,"dose_number":null,"time_to_onset_days":60,"theory_of_causation":"Flu vaccine Oct 8, 2004 → TM (both experts agree on diagnosis; dispute is causation). Dr. Tornatore (petitioner): molecular mimicry; case reports; 5% idiopathic TM within 4 weeks of flu vax = probably vaccine-related; Dr. Sriram's Apr 6 2005 note suggesting postvaccinal etiology. Dr. Bielawski (respondent): only temporal relationship; three large studies (DeStephano, Confavreux, Miller) no increased risk; killed vaccine ≠ live virus; MP not ruled out. SM Oct 20, 2010: DENIED — improperly required 'more likely than not' for Prong 1; discounted case reports via non-vaccine Daubert; used negative epidemiology as affirmative evidence against causation. CFC Judge Williams Apr 29, 2011: VACATED AND REMANDED — Althen Prong 1 standard is biological plausibility, not probability; case reports have evidentiary value; Prong 2 analysis insufficient. Dates correct.","is_death":0,"date_of_death":null,"petition_filed_date":"2007-06-28","case_summary":"The petitioner in this case, identified pseudonymously as John Doe 93, was a \"more or less healthy\" woman in her early sixties when she received a flu vaccination on October 8, 2004. She had received flu vaccinations in prior years without incident. After her October 2004 vaccination, her arm became sore and red. On December 8, 2004 — approximately two months after vaccination — she was diagnosed with a urinary tract infection. On December 12, 2004, she visited the emergency room due to urinary retention and reported abdominal pain beginning around the time of her vaccination. In February 2005 she was evaluated by multiple physicians, including a neurosurgeon who noted that her symptoms had worsened in October 2004. In April 2005, Dr. Subramaniam Sriram at the Multiple Sclerosis Clinic at Vanderbilt University evaluated her. His initial April 6, 2005 medical record noted that her condition was \"probably questionable postinfectious, postvaccination etiology of an acute ascending myelopathy.\" In later visits through 2006, Dr. Sriram listed her diagnosis as \"inflammatory myelopathy of unknown etiology,\" and the question of whether her condition was transverse myelitis, Devic's disease, or postinfectious myelopathy was noted as unresolved. By September 2005, Dr. Karl Misulis had concluded that she was \"permanently and totally disabled\" and diagnosed her with myelopathy/transverse myelitis. Testing ruled out paraneoplastic causes, Devic's disease, and infectious causes: NMO antibodies, paraneoplastic antibodies, and bacterial, fungal, and viral cultures were all negative.\n\nPetitioner filed her petition on June 28, 2007. She submitted a supplemental affidavit in July 2008 stating that Dr. Sriram had told her in 2005 that her neurological problems were caused by her flu vaccination and had advised her to find a vaccine compensation attorney. Petitioner's expert was Dr. Carlo Tornatore, director of the Multiple Sclerosis Center at Georgetown University Hospital, who had treated over 100 transverse myelitis patients. Dr. Tornatore testified that the medical community broadly accepts that vaccination can cause transverse myelitis, and that in his opinion approximately five percent of TM cases remain idiopathic; those occurring within four weeks of flu vaccination were, in his view, probably vaccine-related. He identified molecular mimicry as the most biologically plausible mechanism: flu vaccine proteins stimulate T-cells that can cross the blood-brain barrier and attack myelin in the spinal cord, causing TM. He supported his theory with multiple case reports documenting TM following flu vaccination and with the Wucherpfennig (1995) study identifying structural similarities between influenza A virus peptides and myelin basic protein. He acknowledged that no epidemiological study could be expected to detect such a rare event, explaining that epidemiological studies are designed to assess vaccine safety at the population level, not to determine causal mechanisms in individual cases. The government's expert, Dr. Martin Bielawski of Tufts-New England Medical Center, acknowledged that it was \"possible\" but not probable that the flu vaccine could cause TM. He testified that only the temporal relationship between vaccination and onset tied the vaccine to petitioner's TM, and that three large clinical studies (DeStephano 2003, Confavreux 2001, Miller 1997) found no increased incidence of demyelinating disease following flu vaccination in multiple sclerosis patients. He raised mycoplasma pneumoniae as a potential untested alternative cause.\n\nThe special master issued a decision on October 20, 2010, denying compensation because petitioner had failed to show that the flu vaccine could cause TM. The special master required Dr. Tornatore to demonstrate on a \"more likely than not\" standard that a causal relationship \"likely does in fact exist\" between the flu vaccine and TM — rather than applying the biological plausibility standard that governs Althen's first prong. Using this elevated standard, the special master evaluated the supporting literature in detail, discounted the case reports by analogy to non-vaccine Daubert cases, concluded that the epidemiological studies negatively established that the flu vaccine did not cause TM, and speculated about mycoplasma pneumoniae as an alternative cause despite the absence of any record evidence that petitioner had been diagnosed with that infection. The special master also discounted petitioner's supplemental affidavit about Dr. Sriram's private statement, reasoning that petitioner might have misheard or misunderstood him, and concluded that his contemporaneous treatment notes indicating unknown etiology were more reliable. The special master devoted fewer than two pages to Althen's second prong, without adequately analyzing Dr. Sriram's April 6, 2005 medical note recording a possible postvaccinal etiology.\n\nJudge Williams, writing for the Court of Federal Claims on April 29, 2011, vacated the decision and remanded the case. The court held that the special master had committed legal error by requiring petitioner to prove that it was more likely than not that the flu vaccine can cause TM. Althen's first prong requires only a biologically plausible medical theory, not probability that the theory is correct — a standard consistently applied in Andreu, Walther, and Pafford. The court found that the special master had also improperly discounted case reports by citing non-vaccine Daubert cases (case reports carry evidentiary weight in vaccine proceedings), and had improperly used the epidemiological studies — which simply lacked statistical power to detect rare events — as affirmative evidence against causation. The court further found that speculating about an undiagnosed mycoplasma pneumoniae infection was error in the absence of record evidence and contrary to the testimony of both experts. On the second prong, the court found the analysis insufficient and directed the special master on remand to give proper consideration to Dr. Sriram's April 6, 2005 note — a contemporaneous medical record suggesting a postvaccinal etiology — and to avoid inferring disavowal merely because Dr. Sriram's later notes listed the etiology as unknown (since no test can determine whether a flu vaccine caused TM). The case was remanded for reconsideration of both Althen prongs one and two.","is_minor_inferred":0,"is_pediatric_broad":0,"special_master":null,"petitioner_identifier_original":null,"caption_petitioner_name":null,"petitioner_attorney_name":null,"petitioner_attorney_firm":null,"petitioner_attorney_location":null,"adjudicator_name":null,"caption_people_backfilled_at":null,"attorney_canonical_keys":null,"firm_canonical_key":null,"package_title":"Doe 93 v. Secretary of Health & Human Services","canonical_url":"https://vicp-registry.org/case/USCOURTS-cofc-1_07-vv-00448","plain_text_url":"https://vicp-registry.org/case/USCOURTS-cofc-1_07-vv-00448.txt","json_url":"https://vicp-registry.org/case/USCOURTS-cofc-1_07-vv-00448.json","source_documents":[{"granule_id":"USCOURTS-cofc-1_07-vv-00448-cl6661919","title":"Doe 93 v. Secretary of Health & Human Services","docket_text":"lead-opinion","date_issued":"2011-04-29","pdf_url":"https://www.courtlistener.com/opinion/6778384/doe-93-v-secretary-of-health-human-services/","pdf_bytes":null,"triage_decision":"keep","triage_reason":"recovered via CL opinion 6661919 (html_with_citations)","download_status":"ok","registry_pdf_url":"https://vicp-registry.org/pdf/USCOURTS-cofc-1_07-vv-00448/USCOURTS-cofc-1_07-vv-00448-cl6661919"}]}